Kenneth Sandstöm
Keine laufenden Positionen mehr
Karriereverlauf von Kenneth Sandstöm
Ehemalige bekannte Positionen von Kenneth Sandstöm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AKELA Pharma Oy
 AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Corporate Officer/Principal | - | - |
Leiras
 Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Corporate Officer/Principal | - | - |
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Corporate Officer/Principal | 01.01.2007 | - |
Statistik
International
| Finnland | 4 |
Operativ
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Health Technology |
Leiras
Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Health Technology |
- Börse
- Insiders
- Kenneth Sandstöm
- Erfahrung
